Blood Collection Duct Brand Ranking

Ningbo Yingmed Medical Instruments Co., Ltd is one of the professional supplier for the Medical Instuments products in China. Our Team has more than 15 years experiences in Medical field.   We export our products to customers in Europen, South Africa, South east of Asia, South America, Middle East. We are facroty , located in Jiangsu province, which is near Shanghai port, we produce Oxygen mask, Nebulizer mask, ET tubes, Latex Foley catheter, Tracheostomy tube, Syringe, and etc.   In order to fufill and increasing needs of our trusted and loyal customers, apart from our factory, we have more than 5 strategic partners which produce urine bags, surgical gowns, medical tubes, wound dressing, syringes, diagnostics & lab products.   We care the success of our customers, we know that the important of quality, so we set up a strong QC team stay in differences production lines to ensure & control quality.   Our Company is approved by CE&ISO certificates for most of products.   In future, Yingmed Medical will keep high efficient and professional for every cutomer, and associate company development with human health. We will do our best to put love and respect into our every product, and pass smile to everyone at the world.

Yingmed, VchanseLab

NINGBO YINGMED MEDICAL INSTRUMENTS CO.,LTD

Ningbo Yingmed Medical Instruments Co., Ltd is one of the professional supplier for the Medical Instuments products in China. Our Team has more than 15 years experiences in Medical field.   We export our products to customers in Europen, South Africa, South east of Asia, South America, Middle East. We are facroty , located in Jiangsu province, which is near Shanghai port, we produce Oxygen mask, Nebulizer mask, ET tubes, Latex Foley catheter, Tracheostomy tube, Syringe, and etc.   In order to fufill and increasing needs of our trusted and loyal customers, apart from our factory, we have more than 5 strategic partners which produce urine bags, surgical gowns, medical tubes, wound dressing, syringes, diagnostics & lab products.   We care the success of our customers, we know that the important of quality, so we set up a strong QC team stay in differences production lines to ensure & control quality.   Our Company is approved by CE&ISO certificates for most of products.   In future, Yingmed Medical will keep high efficient and professional for every cutomer, and associate company development with human health. We will do our best to put love and respect into our every product, and pass smile to everyone at the world.

Weigao was founded in 1988. With the simple and kindness of improving the lives of the elderly and widowed, he set up a small workshop in the township welfare home. Currently committed to developing its main business medical devices and medicine, covering an area of ​​more than 6 million square meters, it has 13 industrial groups and more than 100 subsidiaries, including 3 listed companies and 8 overseas companies, and is located in 10 provinces and cities in China. A manufacturing base is built with more than 30,000 employees. We have always taken improving national health and breaking foreign monopoly as our mission. We have now become a global supplier of comprehensive, safe, reliable and trustworthy overall solutions for medical systems. Create a systematic R&D platform to enhance core competitiveness through innovation and enrich product structure. 15 national and provincial innovation platforms have been built, including the National Certified Enterprise Technology Center, National Engineering Research Center, National Innovation Pilot Enterprise, Academician Workstation, Postdoctoral Workstation, Taishan Scholar Laboratory, etc., and many other institutions, including the Chinese Academy of Sciences, the Chinese Academy of Engineering, 301 Hospital, etc. Our unit has carried out industry-university-research cooperation and established cooperative relationships with more than 100 academicians. It has more than 1,700 patents, more than 1,000 medical devices and drugs, and more than 200,000 specifications. Committed to solving the "bottleneck" problem in foreign countries, overcome 21 technical barriers, achieve domestic substitution for more than 100 products, undertake more than 30 national key projects, win 4 national scientific and technological progress awards, 2 national technological invention awards, and national excellent industry 1 gold medal in design. Adhere to scientific management and improve the management system. It has a national technical standard innovation base and a national certification and testing center, and has 1 international standards formulated by enterprises in the industry and 2 international standards proposals, leading or participating in 11 national standards. Improve product quality with advanced manufacturing technology, introduce advanced domestic and foreign automated production equipment, establish management systems such as intelligent manufacturing (MES), AI visual inspection, quality BI data, etc., continuously improve management and control processes, and carry out digital transformation to continuously improve production and manufacturing capabilities and Management level. Improve industrial layout, lay out chains, strengthen chains, and extend chains. Establish an industrial layout of the coordinated development of three types of business formats to create a medical ecological chain. The medical industry has focused on creating product lines such as clinical nursing, orthopedics, blood purification, drug packaging, medical intervention, surgical robots, and medical engineering. It ranks among the top in the country in terms of product lines such as nursing, hemodialysis, pharmaceutical packaging materials, and blood technology. The sales network is spread all over the country and abroad, with more than 100 sales offices, and has created the "Jierui" and "Vigao" brands, and its products are sold to more than 100 countries or regions around the world.

WEGO

Weigao Group Co., Ltd.

Weigao was founded in 1988. With the simple and kindness of improving the lives of the elderly and widowed, he set up a small workshop in the township welfare home. Currently committed to developing its main business medical devices and medicine, covering an area of ​​more than 6 million square meters, it has 13 industrial groups and more than 100 subsidiaries, including 3 listed companies and 8 overseas companies, and is located in 10 provinces and cities in China. A manufacturing base is built with more than 30,000 employees. We have always taken improving national health and breaking foreign monopoly as our mission. We have now become a global supplier of comprehensive, safe, reliable and trustworthy overall solutions for medical systems. Create a systematic R&D platform to enhance core competitiveness through innovation and enrich product structure. 15 national and provincial innovation platforms have been built, including the National Certified Enterprise Technology Center, National Engineering Research Center, National Innovation Pilot Enterprise, Academician Workstation, Postdoctoral Workstation, Taishan Scholar Laboratory, etc., and many other institutions, including the Chinese Academy of Sciences, the Chinese Academy of Engineering, 301 Hospital, etc. Our unit has carried out industry-university-research cooperation and established cooperative relationships with more than 100 academicians. It has more than 1,700 patents, more than 1,000 medical devices and drugs, and more than 200,000 specifications. Committed to solving the "bottleneck" problem in foreign countries, overcome 21 technical barriers, achieve domestic substitution for more than 100 products, undertake more than 30 national key projects, win 4 national scientific and technological progress awards, 2 national technological invention awards, and national excellent industry 1 gold medal in design. Adhere to scientific management and improve the management system. It has a national technical standard innovation base and a national certification and testing center, and has 1 international standards formulated by enterprises in the industry and 2 international standards proposals, leading or participating in 11 national standards. Improve product quality with advanced manufacturing technology, introduce advanced domestic and foreign automated production equipment, establish management systems such as intelligent manufacturing (MES), AI visual inspection, quality BI data, etc., continuously improve management and control processes, and carry out digital transformation to continuously improve production and manufacturing capabilities and Management level. Improve industrial layout, lay out chains, strengthen chains, and extend chains. Establish an industrial layout of the coordinated development of three types of business formats to create a medical ecological chain. The medical industry has focused on creating product lines such as clinical nursing, orthopedics, blood purification, drug packaging, medical intervention, surgical robots, and medical engineering. It ranks among the top in the country in terms of product lines such as nursing, hemodialysis, pharmaceutical packaging materials, and blood technology. The sales network is spread all over the country and abroad, with more than 100 sales offices, and has created the "Jierui" and "Vigao" brands, and its products are sold to more than 100 countries or regions around the world.

The VACUETTE® non-replaceable specimen collection system produced by Greiner Bio-One in Austria is made of environmentally friendly materials such as PET. Suitable for the collection of specimens in hospitals and laboratory and the supporting use of existing detection instruments. Raw materials have been certified by the EU environmental protection; radiative sterilization; different color and color of the head cover are different from different blood collection tube types; screw-pull covers to prevent aerosol pollution and ensure safe storage and transportation; there is also MiniCollect trace peripheral blood collection system and urine system , blood sedimentation detection system and transportation system.

VACUETTE

Beijing Greena Jianfeng Biotechnology Co., Ltd.

The VACUETTE® non-replaceable specimen collection system produced by Greiner Bio-One in Austria is made of environmentally friendly materials such as PET. Suitable for the collection of specimens in hospitals and laboratory and the supporting use of existing detection instruments. Raw materials have been certified by the EU environmental protection; radiative sterilization; different color and color of the head cover are different from different blood collection tube types; screw-pull covers to prevent aerosol pollution and ensure safe storage and transportation; there is also MiniCollect trace peripheral blood collection system and urine system , blood sedimentation detection system and transportation system.

Import channels were interrupted during World War I, and Japanese medical scientists made efforts to localize the thermometers as their goal. In 1921, medical scientists led by Dr. Shibasaburo Kitari founded the Telmao Company. Since its establishment, Termau has inherited the innovative challenge spirit of Dr. Beili, implemented the company philosophy of "contributing to society through medical care", and is committed to delivering excellent innovative technologies to the medical site. Telmao Co., Ltd. was founded in 1921. Its products include disposable medical devices, blood transfusion tools series, pharmaceutical and nutritional medicine series, angiography and therapeutic catheter, medical electronic products series, artificial heart and lung product series, etc. Termau's products have been widely used in many countries and regions around the world. Termau's unique technology will make the medical process humanized and gentle. The application of Telmao's new technology can relieve pain and discomfort during medical treatment as much as possible. Telmau has always been committed to developing medical products that meet high standards, not only meeting high standards in terms of safety and precision, but also in maintaining patients' good recovery and quality of life. At present, Telmao has established two factories in Hangzhou and Changchun, China respectively. Termau will dedicate mild, easy-to-use healthcare products and technologies to the world in the 21st century. In order to strengthen the integrated management of R&D, production and sales in China, Telmao applied for the establishment of Telmao (China) Investment Co., Ltd. in August 2012, with a registered capital of US$30 million. According to the early business strategy, the sales ratio of domestic products will be gradually increased in the future. The establishment of Telmao (China) Investment Co., Ltd. has also taken a big step to integrating the Greater China Circle Management Model in the Mainland, Hong Kong, Macau and Taiwan markets.

TERUMO

Terumo (China) Investment Co., Ltd.

Import channels were interrupted during World War I, and Japanese medical scientists made efforts to localize the thermometers as their goal. In 1921, medical scientists led by Dr. Shibasaburo Kitari founded the Telmao Company. Since its establishment, Termau has inherited the innovative challenge spirit of Dr. Beili, implemented the company philosophy of "contributing to society through medical care", and is committed to delivering excellent innovative technologies to the medical site. Telmao Co., Ltd. was founded in 1921. Its products include disposable medical devices, blood transfusion tools series, pharmaceutical and nutritional medicine series, angiography and therapeutic catheter, medical electronic products series, artificial heart and lung product series, etc. Termau's products have been widely used in many countries and regions around the world. Termau's unique technology will make the medical process humanized and gentle. The application of Telmao's new technology can relieve pain and discomfort during medical treatment as much as possible. Telmau has always been committed to developing medical products that meet high standards, not only meeting high standards in terms of safety and precision, but also in maintaining patients' good recovery and quality of life. At present, Telmao has established two factories in Hangzhou and Changchun, China respectively. Termau will dedicate mild, easy-to-use healthcare products and technologies to the world in the 21st century. In order to strengthen the integrated management of R&D, production and sales in China, Telmao applied for the establishment of Telmao (China) Investment Co., Ltd. in August 2012, with a registered capital of US$30 million. According to the early business strategy, the sales ratio of domestic products will be gradually increased in the future. The establishment of Telmao (China) Investment Co., Ltd. has also taken a big step to integrating the Greater China Circle Management Model in the Mainland, Hong Kong, Macau and Taiwan markets.

Jishui Medical Technology (China) Co., Ltd. is a wholly-owned subsidiary of Jishui Chemical Industry Co., Ltd., and its former subsidiary of Jishui Chemical Industry Co., Ltd., "Beijing Jishui Chuangge Medical Technology Co., Ltd.", and Jishui Medical "Shanghai Dayi IQT Trading Co., Ltd." is a wholly owned subsidiary of Japan First Chemical Pharmaceutical Co., Ltd. in China. Beijing Jishui Chuangge Medical Technology Co., Ltd. is a joint venture jointly established by Japan Jishui Chemical Industry Co., Ltd. and domestic listed company China Youth Travel Holdings Co., Ltd. in 2003. The company has a registered capital of US$12 million and a total investment of US$29 million. Jishui Chemical Industry Co., Ltd. has started producing PET vacuum blood collection tubes since 1985, and has its own cutting-edge production technology, especially PET original pipe manufacturing device, serum separator filling device, agent dispensing device, etc., which are Jishui Chemical after years of research. Developed highly specialized precision instruments. The INSEPACK vacuum blood collection vessel produced by Jishui Chuangge, all the raw materials used for the preparations and separation glues are independently developed by Jishui Chemical Industry Co., Ltd. The strong technical strength has laid a solid foundation for INSEPACK's vacuum blood collection products to go global and serve medical services. In February 2010, "Beijing Jishui Chuangge Medical Technology Co., Ltd." became the sole proprietorship and became the "Jishui Medical Technology (China) Co., Ltd." fully invested by Jishui Chemical Industry Co., Ltd. Shanghai Dayi IC Trading Co., Ltd. was established in September 2006 and is a 100% capital and held by Japan First Chemical Pharmaceuticals Co., Ltd. First Chemical Pharmaceuticals Co., Ltd. was founded on July 1, 1947 and is headquartered in Tokyo, Japan. It is one of the earliest manufacturers of clinical diagnostic reagents in Japan. The HDL-C and LDL-C detection kits produced by "Japan Yihua" have been the first in the world to obtain the certification of the US CDC and have enjoyed a long-term reputation around the world. In 2006, First Chemical Pharmaceutical Co., Ltd. was wholly acquired by Jishui Chemical Industry Co., Ltd. In 2008, Jishui Medical Co., Ltd., which is based on Japan First Chemical Pharmaceutical Co., Ltd. and integrates the medical department of Jishui Chemical Industry Co., Ltd., was established. Shanghai Dayi ICT Trade Co., Ltd. was changed to a wholly-owned subsidiary of Jishui Medical Co., Ltd. company. In order to strengthen the market management, after-sales service and market development of Jishui medical products in the Chinese market, in October 2010, Jishui Medical Technology (China) Co., Ltd. and Shanghai Dayi ICT Trade Co., Ltd. integrated their business and formed a new one. Jishui Medical Technology (China) Co., Ltd. The integrated Jishui Medical Technology (China) Co., Ltd. is one of the subsidiaries of Jishui Chemical Industry Co., Ltd., whose business is under the management and guidance of Jishui Medical Co., Ltd., and its business areas cover the production and sales of vacuum blood collection vessels, in vitro diagnostic reagents, Import and sales of clinical testing and analysis instruments, as well as related technical consultation, technical services, etc. At present, Jishui Medical Technology (China) Co., Ltd. has obtained more than 110 registered products, covering many fields such as coagulation, biochemistry, drug concentration, POCT, disposable vacuum blood collection vessels, etc., and has continuously introduced new products. In addition, 23 branches have been established in various provinces in China, and a sales network covering the country and a professional after-sales service guarantee team have been established. The vacuum blood collection tube factory has obtained ISO9001 medical device quality management system certification, CE product certification, IVD certification, Japan GMP and other certifications. The products are sold nationwide and exported to Japan. Jishui Medical Technology (China) Co., Ltd. will continue to take the purpose of "customer satisfaction and product quality first", and will support the rapid development and popularization of medical technology at home and abroad as its mission, and make the development of the world's medical industry and human health. Deserved contribution!

Sekisui Medical

Sekisui Medical Technology (China) Co., Ltd.

Jishui Medical Technology (China) Co., Ltd. is a wholly-owned subsidiary of Jishui Chemical Industry Co., Ltd., and its former subsidiary of Jishui Chemical Industry Co., Ltd., "Beijing Jishui Chuangge Medical Technology Co., Ltd.", and Jishui Medical "Shanghai Dayi IQT Trading Co., Ltd." is a wholly owned subsidiary of Japan First Chemical Pharmaceutical Co., Ltd. in China. Beijing Jishui Chuangge Medical Technology Co., Ltd. is a joint venture jointly established by Japan Jishui Chemical Industry Co., Ltd. and domestic listed company China Youth Travel Holdings Co., Ltd. in 2003. The company has a registered capital of US$12 million and a total investment of US$29 million. Jishui Chemical Industry Co., Ltd. has started producing PET vacuum blood collection tubes since 1985, and has its own cutting-edge production technology, especially PET original pipe manufacturing device, serum separator filling device, agent dispensing device, etc., which are Jishui Chemical after years of research. Developed highly specialized precision instruments. The INSEPACK vacuum blood collection vessel produced by Jishui Chuangge, all the raw materials used for the preparations and separation glues are independently developed by Jishui Chemical Industry Co., Ltd. The strong technical strength has laid a solid foundation for INSEPACK's vacuum blood collection products to go global and serve medical services. In February 2010, "Beijing Jishui Chuangge Medical Technology Co., Ltd." became the sole proprietorship and became the "Jishui Medical Technology (China) Co., Ltd." fully invested by Jishui Chemical Industry Co., Ltd. Shanghai Dayi IC Trading Co., Ltd. was established in September 2006 and is a 100% capital and held by Japan First Chemical Pharmaceuticals Co., Ltd. First Chemical Pharmaceuticals Co., Ltd. was founded on July 1, 1947 and is headquartered in Tokyo, Japan. It is one of the earliest manufacturers of clinical diagnostic reagents in Japan. The HDL-C and LDL-C detection kits produced by "Japan Yihua" have been the first in the world to obtain the certification of the US CDC and have enjoyed a long-term reputation around the world. In 2006, First Chemical Pharmaceutical Co., Ltd. was wholly acquired by Jishui Chemical Industry Co., Ltd. In 2008, Jishui Medical Co., Ltd., which is based on Japan First Chemical Pharmaceutical Co., Ltd. and integrates the medical department of Jishui Chemical Industry Co., Ltd., was established. Shanghai Dayi ICT Trade Co., Ltd. was changed to a wholly-owned subsidiary of Jishui Medical Co., Ltd. company. In order to strengthen the market management, after-sales service and market development of Jishui medical products in the Chinese market, in October 2010, Jishui Medical Technology (China) Co., Ltd. and Shanghai Dayi ICT Trade Co., Ltd. integrated their business and formed a new one. Jishui Medical Technology (China) Co., Ltd. The integrated Jishui Medical Technology (China) Co., Ltd. is one of the subsidiaries of Jishui Chemical Industry Co., Ltd., whose business is under the management and guidance of Jishui Medical Co., Ltd., and its business areas cover the production and sales of vacuum blood collection vessels, in vitro diagnostic reagents, Import and sales of clinical testing and analysis instruments, as well as related technical consultation, technical services, etc. At present, Jishui Medical Technology (China) Co., Ltd. has obtained more than 110 registered products, covering many fields such as coagulation, biochemistry, drug concentration, POCT, disposable vacuum blood collection vessels, etc., and has continuously introduced new products. In addition, 23 branches have been established in various provinces in China, and a sales network covering the country and a professional after-sales service guarantee team have been established. The vacuum blood collection tube factory has obtained ISO9001 medical device quality management system certification, CE product certification, IVD certification, Japan GMP and other certifications. The products are sold nationwide and exported to Japan. Jishui Medical Technology (China) Co., Ltd. will continue to take the purpose of "customer satisfaction and product quality first", and will support the rapid development and popularization of medical technology at home and abroad as its mission, and make the development of the world's medical industry and human health. Deserved contribution!

Chengdu Ruiqi Medical Technology Co., Ltd. was founded in 1998. The company is mainly committed to the research, development, production, sales and services of medical specimen collection systems, microbial detection systems, biotechnology and information technology, and provides hospital logistics refinement and intelligence. Solutions, and incubation of venture capital in the medical and health field. The shareholding reform was completed in 2013, and the New Third Board was successfully listed in August 2014 (Stock code: 831079). The company's main products include: vacuum blood collection system, body fluid specimen collection system, puncture needles, biological containers, microbial culture identification system, fully automatic staining machine, bioinformatics technology, experimental instruments, experimental reagents and standards, etc. The products are widely used in hospitals, disease control, blood stations, physical examination centers, health care, pharmaceutical and equipment manufacturing, scientific research, teaching and other fields. Through rigorous process flow and professional production team, the company has established a strict product quality assurance system to ensure long-lasting and stable quality. It now has a 100,000-level purification workshop with a total of more than 1,000 square meters. It has successively introduced advanced equipment and relied on medical institutions and research institutes to jointly establish multiple clinical experimental bases. The company has passed the EU ENISO13485:2016 medical device quality management system certification and product CE certification, paving the way for entering the international market. After more than 20 years of development, the company's sales network is spread all over the world, and its products have been widely used in major and medium-sized hospitals across the country. It has thousands of users in China, including more than 100 Class A hospitals. The company has also made great progress in its foreign sales market. Its products have been exported in batches to more than 90 countries and regions abroad, and enjoys a high reputation in Asia, Africa, Europe and the Americas. Chengdu Ruiqi is based in China and looks at the world. We will continue to follow the tenet of "Ruiqi Technology, everyone benefits", through unremitting efforts, provide cost-effective products and services to the world, effectively ensure the safety of medical staff, and contribute to the development of human health and medical services through unremitting efforts. .

CDRICH

Chengdu Ruiqi Medical Technology Co., Ltd.

Chengdu Ruiqi Medical Technology Co., Ltd. was founded in 1998. The company is mainly committed to the research, development, production, sales and services of medical specimen collection systems, microbial detection systems, biotechnology and information technology, and provides hospital logistics refinement and intelligence. Solutions, and incubation of venture capital in the medical and health field. The shareholding reform was completed in 2013, and the New Third Board was successfully listed in August 2014 (Stock code: 831079). The company's main products include: vacuum blood collection system, body fluid specimen collection system, puncture needles, biological containers, microbial culture identification system, fully automatic staining machine, bioinformatics technology, experimental instruments, experimental reagents and standards, etc. The products are widely used in hospitals, disease control, blood stations, physical examination centers, health care, pharmaceutical and equipment manufacturing, scientific research, teaching and other fields. Through rigorous process flow and professional production team, the company has established a strict product quality assurance system to ensure long-lasting and stable quality. It now has a 100,000-level purification workshop with a total of more than 1,000 square meters. It has successively introduced advanced equipment and relied on medical institutions and research institutes to jointly establish multiple clinical experimental bases. The company has passed the EU ENISO13485:2016 medical device quality management system certification and product CE certification, paving the way for entering the international market. After more than 20 years of development, the company's sales network is spread all over the world, and its products have been widely used in major and medium-sized hospitals across the country. It has thousands of users in China, including more than 100 Class A hospitals. The company has also made great progress in its foreign sales market. Its products have been exported in batches to more than 90 countries and regions abroad, and enjoys a high reputation in Asia, Africa, Europe and the Americas. Chengdu Ruiqi is based in China and looks at the world. We will continue to follow the tenet of "Ruiqi Technology, everyone benefits", through unremitting efforts, provide cost-effective products and services to the world, effectively ensure the safety of medical staff, and contribute to the development of human health and medical services through unremitting efforts. .

Ningbo Siny Medical Technology Co., Ltd is a subsidiary of Anhui Sinic Laboratory Medical Technology Co., Ltd , which was established in 2003. It is a scientific and technological enterprise, integrating R&D,production and sales of medical devices. The factory is located in Tongcheng city (which is near to Shanghai seaport), covering an area of 12,000 square meters. Our main products are blood collection tubes, virus sampling tubes, blood collection needles, and sanitizers,safety syringe,PRP tube which we sell to over 40 different countries."Integrity, innovation, service, eternity" is the company's corporate spirit, actively pioneering and innovating, developing and applying internationally advanced medical testing technology, and working hard to practice "science and technology the primary productive force" to contribute to human health causes.

SINY

Ningbo Siny Medical Technology Co., Ltd

Ningbo Siny Medical Technology Co., Ltd is a subsidiary of Anhui Sinic Laboratory Medical Technology Co., Ltd , which was established in 2003. It is a scientific and technological enterprise, integrating R&D,production and sales of medical devices. The factory is located in Tongcheng city (which is near to Shanghai seaport), covering an area of 12,000 square meters. Our main products are blood collection tubes, virus sampling tubes, blood collection needles, and sanitizers,safety syringe,PRP tube which we sell to over 40 different countries."Integrity, innovation, service, eternity" is the company's corporate spirit, actively pioneering and innovating, developing and applying internationally advanced medical testing technology, and working hard to practice "science and technology the primary productive force" to contribute to human health causes.

Chengdu Push Medical Plastic Packaging Co., Ltd. is a wholly-owned subsidiary of Wuliangye Push Group. It was established in 2006 with a registered capital of RMB 350 million. Push Medical is located in the high-tech development zone in western Chengdu, China. It has invested more than 500 million yuan. It is a medical plastic product manufacturer integrating R&D, production and sales. Passed and obtained ISO9001, ISO13485 quality system certification, CE certification, Sichuan Provincial Food and Drug Administration quality system review, and the State Food and Drug Administration GMP certification. Chengdu Push is a manufacturer integrating R&D, production and sales, from raw material R&D, mold design and processing to production from semi-finished products to finished products. Push uses high-quality raw materials made by DuPont technology in the United States to control quality from the source. Homemade high-quality plastic raw materials control the quality of the product from the source, and the 10,000-degree clean room avoids cleaning of each tube, ensuring the smoothness of the inner wall of the tube and avoiding secondary treatment. The products include a complete blood collection system, a vacuum blood collection tube for a single use, a vacuum blood collection needle for a single use, a vacuum blood collection needle pen type for a single use, a flashback blood collection needle for a single use, and a safe blood collection needle group for a single use. Two-piece syringes, tourniquets, plastic infusion ports and some other common medical components.

Push Medical Plastics

Chengdu Push Medical Technology Co., Ltd.

Chengdu Push Medical Plastic Packaging Co., Ltd. is a wholly-owned subsidiary of Wuliangye Push Group. It was established in 2006 with a registered capital of RMB 350 million. Push Medical is located in the high-tech development zone in western Chengdu, China. It has invested more than 500 million yuan. It is a medical plastic product manufacturer integrating R&D, production and sales. Passed and obtained ISO9001, ISO13485 quality system certification, CE certification, Sichuan Provincial Food and Drug Administration quality system review, and the State Food and Drug Administration GMP certification. Chengdu Push is a manufacturer integrating R&D, production and sales, from raw material R&D, mold design and processing to production from semi-finished products to finished products. Push uses high-quality raw materials made by DuPont technology in the United States to control quality from the source. Homemade high-quality plastic raw materials control the quality of the product from the source, and the 10,000-degree clean room avoids cleaning of each tube, ensuring the smoothness of the inner wall of the tube and avoiding secondary treatment. The products include a complete blood collection system, a vacuum blood collection tube for a single use, a vacuum blood collection needle for a single use, a vacuum blood collection needle pen type for a single use, a flashback blood collection needle for a single use, and a safe blood collection needle group for a single use. Two-piece syringes, tourniquets, plastic infusion ports and some other common medical components.

Bidi Medical is a global medical technology company that leads the world's health by improving medical discovery methods, medical diagnostic effects and care quality. Bidi Medical focuses and supports every front-line medical worker, and is committed to helping patients improve clinical treatment through the development of innovative technologies, services and solutions, and helping medical staff improve clinical processes. Beddy Medical and its 75,000 global employees uphold a high level of enthusiasm and belief to provide clinical medical staff with a safe and efficient nursing delivery process, assist laboratory scientists in diagnosing diseases more effectively, and enhance the research and development of a new generation of diagnosis and Ability to treat diseases. Bidi Medical has branches in almost all countries and actively cooperates with organizations around the world to work together to address challenging global health issues. Through close collaboration with customers, Bidi Medical takes it as its mission to improve treatment outcomes, reduce medical costs, and improve diagnostic efficiency, helping to strengthen the safety of patients and medical staff and expand medical access. In 1994, Bidi Medical officially sent personnel to register and establish a representative agency in China to carry out business with China. Currently, it has formed a regional headquarters with Shanghai, with offices in cities such as Beijing, Guangzhou, and Chengdu, with nearly 4,000 employees. In the past 30 years, Bidi Medical has adhered to the concept of "rooted in China, serving China" (In China, For China), and is committed to building high-quality local multinational medical technology companies, with a total investment of hundreds of millions of dollars and building three major local factories. 2 R&D centers and 1 customer service center, and a customer experience center, several professional training centers and laboratories, as well as the comprehensive Bidi Medical Greater China Innovation Center officially completed in 2023, actively practicing health care China 2030 will benefit more Chinese patients and medical workers and help promote the progress of medical industry.

Becton, Dickinson and Company(BD)

BD Medical Devices (Shanghai) Co., Ltd.

Bidi Medical is a global medical technology company that leads the world's health by improving medical discovery methods, medical diagnostic effects and care quality. Bidi Medical focuses and supports every front-line medical worker, and is committed to helping patients improve clinical treatment through the development of innovative technologies, services and solutions, and helping medical staff improve clinical processes. Beddy Medical and its 75,000 global employees uphold a high level of enthusiasm and belief to provide clinical medical staff with a safe and efficient nursing delivery process, assist laboratory scientists in diagnosing diseases more effectively, and enhance the research and development of a new generation of diagnosis and Ability to treat diseases. Bidi Medical has branches in almost all countries and actively cooperates with organizations around the world to work together to address challenging global health issues. Through close collaboration with customers, Bidi Medical takes it as its mission to improve treatment outcomes, reduce medical costs, and improve diagnostic efficiency, helping to strengthen the safety of patients and medical staff and expand medical access. In 1994, Bidi Medical officially sent personnel to register and establish a representative agency in China to carry out business with China. Currently, it has formed a regional headquarters with Shanghai, with offices in cities such as Beijing, Guangzhou, and Chengdu, with nearly 4,000 employees. In the past 30 years, Bidi Medical has adhered to the concept of "rooted in China, serving China" (In China, For China), and is committed to building high-quality local multinational medical technology companies, with a total investment of hundreds of millions of dollars and building three major local factories. 2 R&D centers and 1 customer service center, and a customer experience center, several professional training centers and laboratories, as well as the comprehensive Bidi Medical Greater China Innovation Center officially completed in 2023, actively practicing health care China 2030 will benefit more Chinese patients and medical workers and help promote the progress of medical industry.

Yangpu Medical Technology Co., Ltd. (hereinafter referred to as "Company" or "Yangpu Medical", stock code: 300030) was established in 1996. It is a national high-tech enterprise engaged in research on pre-specimen analysis and variation control for nearly 26 years. It has become a domestic one. It is the leader in the field of intravenous specimen collection and ranks among the best in the world. In 2009, Yangpu Medical entered the Shenzhen Stock Exchange GEM. Against the backdrop of the transformation of global medical institutions from traditional diagnosis and treatment to full-cycle service of "prevention, diagnosis, treatment, rehabilitation and health management", the company relies on its listing advantages and takes the vacuum blood collection system business as the starting point, and is based on its precision medicine and intelligence Medical care and third-party special examinations with early tumor screening and accompanying diagnosis as the core are made important strategic layouts. Focusing on the fields of IVD and digital medical care, adhering to the dual-wheel drive of "precision medical + smart medical care", products and services cover the entire chain of clinical laboratories from specimen collection, diagnostic monitoring, real-time inspection, and data management. The market is spread across more than 100 countries around the world and Regionally, it provides products and technical services to nearly 10,000 well-known medical institutions.

IMPROVE

Yangpu Medical Technology Co., Ltd.

Yangpu Medical Technology Co., Ltd. (hereinafter referred to as "Company" or "Yangpu Medical", stock code: 300030) was established in 1996. It is a national high-tech enterprise engaged in research on pre-specimen analysis and variation control for nearly 26 years. It has become a domestic one. It is the leader in the field of intravenous specimen collection and ranks among the best in the world. In 2009, Yangpu Medical entered the Shenzhen Stock Exchange GEM. Against the backdrop of the transformation of global medical institutions from traditional diagnosis and treatment to full-cycle service of "prevention, diagnosis, treatment, rehabilitation and health management", the company relies on its listing advantages and takes the vacuum blood collection system business as the starting point, and is based on its precision medicine and intelligence Medical care and third-party special examinations with early tumor screening and accompanying diagnosis as the core are made important strategic layouts. Focusing on the fields of IVD and digital medical care, adhering to the dual-wheel drive of "precision medical + smart medical care", products and services cover the entire chain of clinical laboratories from specimen collection, diagnostic monitoring, real-time inspection, and data management. The market is spread across more than 100 countries around the world and Regionally, it provides products and technical services to nearly 10,000 well-known medical institutions.

Wuxi GUKANG Medical Equipment Co.,Ltd is set up in 2000,located in Wuxi Jiangyin where about 2 hours' drive from Shanghai.We have witnessed the vigorous development of the medical device industry,and have also been continuously optimizing its own infrastructure equipment and personnel as the industry becomes more standardize.Usually we have customized services for each customer in order to provide the heroes on the frontlines of healthcare with safer and more convenient products.Stable quality and Patient service have helped us accumulate a lot of customer resources,from which we have also gained rich experience so that we can provide customers with professional and diversified solutions in the future.

Member Station: gukang.store.bossgoo.com
Gukang

Wuxi Gukang Medical Equipment Co., Ltd.

Wuxi GUKANG Medical Equipment Co.,Ltd is set up in 2000,located in Wuxi Jiangyin where about 2 hours' drive from Shanghai.We have witnessed the vigorous development of the medical device industry,and have also been continuously optimizing its own infrastructure equipment and personnel as the industry becomes more standardize.Usually we have customized services for each customer in order to provide the heroes on the frontlines of healthcare with safer and more convenient products.Stable quality and Patient service have helped us accumulate a lot of customer resources,from which we have also gained rich experience so that we can provide customers with professional and diversified solutions in the future.

Member Station: gukang.store.bossgoo.com

Zhejiang Gongdong Medical Equipment Co., Ltd. was founded in 1985. It is a high-tech enterprise specializing in the research, development, production and sales of disposable medical consumables. Gongdong adheres to the concept of "high quality, high efficiency, development and prosperity together", takes it as its mission to promote the development of the medical consumables industry, and continuously improves the product technical content and product quality. After more than 30 years of dedicated development, it continues to expand its products. The depth and breadth of the line have now become a relatively complete range of products and a larger scale among domestic disposable medical consumables manufacturers. In September 2020, the company was listed on the Shanghai Stock Exchange with the stock code 605369.SH. The company actively deploys domestic and international markets and continuously increases its market share. In the domestic market, on the one hand, the company cooperates with many powerful dealers; on the other hand, it insists on building a marketing team with professional qualities, responsible for developing and maintaining end customers. At the same time, the company focuses on after-sales service for terminal customers, and major provinces and cities have dedicated personnel to be responsible for product after-sales service to quickly respond to terminal customers' needs. At present, the company has established a good brand image in the domestic disposable medical consumables industry and has established a good reputation among the customer base of second-level and above hospitals in the country. The domestic sales network has covered most provinces and cities across the country, including more than 1,600 dealers and more than 560 direct customers. In the international market, on the one hand, the company has formed long-term and stable partnerships with many internationally renowned customers in the field of medical consumables, such as McKesson, IDEXX, Corning, Medline, ThermoFisher, AsOne and other companies; on the other hand, it has carried out long-term and stable partnerships with domestic and foreign traders; on the other hand, it has carried out Business cooperation, make full use of its distribution network, and maintain and expand overseas market share. At present, the company's products are sold to more than 100 countries including Europe, America, Asia, Africa, etc.

GONGDONG

Zhejiang Gongdong Medical Device Co., Ltd.

Zhejiang Gongdong Medical Equipment Co., Ltd. was founded in 1985. It is a high-tech enterprise specializing in the research, development, production and sales of disposable medical consumables. Gongdong adheres to the concept of "high quality, high efficiency, development and prosperity together", takes it as its mission to promote the development of the medical consumables industry, and continuously improves the product technical content and product quality. After more than 30 years of dedicated development, it continues to expand its products. The depth and breadth of the line have now become a relatively complete range of products and a larger scale among domestic disposable medical consumables manufacturers. In September 2020, the company was listed on the Shanghai Stock Exchange with the stock code 605369.SH. The company actively deploys domestic and international markets and continuously increases its market share. In the domestic market, on the one hand, the company cooperates with many powerful dealers; on the other hand, it insists on building a marketing team with professional qualities, responsible for developing and maintaining end customers. At the same time, the company focuses on after-sales service for terminal customers, and major provinces and cities have dedicated personnel to be responsible for product after-sales service to quickly respond to terminal customers' needs. At present, the company has established a good brand image in the domestic disposable medical consumables industry and has established a good reputation among the customer base of second-level and above hospitals in the country. The domestic sales network has covered most provinces and cities across the country, including more than 1,600 dealers and more than 560 direct customers. In the international market, on the one hand, the company has formed long-term and stable partnerships with many internationally renowned customers in the field of medical consumables, such as McKesson, IDEXX, Corning, Medline, ThermoFisher, AsOne and other companies; on the other hand, it has carried out long-term and stable partnerships with domestic and foreign traders; on the other hand, it has carried out Business cooperation, make full use of its distribution network, and maintain and expand overseas market share. At present, the company's products are sold to more than 100 countries including Europe, America, Asia, Africa, etc.

Sanli Group was established in 1991 and its predecessor was Liuyang Medical Instrument Factory in Hunan Province. The headquarters is located in Liuyang, Hunan, the capital of China's beautiful fireworks. Located on National Highway 319, 50 kilometers away from Changsha, the provincial capital, and 32 kilometers away from Huanghua Airport, it has convenient transportation. The group covers an area of ​​130,000 square meters and currently has more than 200 employees. It has "Sanli Medical Technology, Benkang Plastic Products Branch, Reagent Project Department, Medical Glove Project Department" and other business industries. The total assets exceed 1 billion yuan and the annual output value reaches 800 million yuan. "Sanli" is a group enterprise integrating science, industry and trade. It is the earliest single-use automatic venous blood collector company in China and even Asia with excellent equipment, stable quality and high market share. Leading enterprises and blood collection vessel production bases. The group has formed a complete production chain in the production process of disposable automatic venous blood collectors. In addition to self-production and self-use, the supporting components, additives, automatic production lines of blood collectors are also sold to the vast number of blood collector manufacturers and scientific research institutions at home and abroad. The group's production, testing technology and equipment are at the forefront of the world. It has developed and produced more than 100 leading products of different specifications and functions. Glass pipes and PET pipes are sterile pipes. It is currently a domestically produced glass. Manufacturer of sterile tubes. "Sanli" participated in the formulation of vacuum blood collection industry standards. It is a sentinel unit for adverse event monitoring of vacuum blood collection products designated by the State Food and Drug Administration. It is a medical foreign aid training base designated by the Ministry of Commerce. In 2017, the total training came from 277 medical foreign aid workers in 126 countries. The group currently has 6 production workshops and 14 management departments, with more than 60 offices and more than 1,500 operating companies across the country are responsible for the company's product promotion and sales. In addition to the domestic market, the products are also sold to Asia, Europe, the United States and Africa. 74 countries including 32 in Asia, 18 in Africa, 15 in Europe, and 9 in the Americas; the group has passed ISO9001:2015 and ISO13485:2012 international quality management system certification and EU CE certification, providing strong guarantees for product quality . The "Three Forces" are a perfect combination of time, place and people, and are a beacon of scientific and technological innovation. Based in Asia, looking around the world, advocating people-oriented, keeping pace with the times, turning ideas and vows into motivation for hard work and progress, the "three forces" will surely become the leader in the global disposable automatic venous blood collector industry!

Brand Three Forces

Liuyang Sanli Medical Technology Development Co., Ltd.

Sanli Group was established in 1991 and its predecessor was Liuyang Medical Instrument Factory in Hunan Province. The headquarters is located in Liuyang, Hunan, the capital of China's beautiful fireworks. Located on National Highway 319, 50 kilometers away from Changsha, the provincial capital, and 32 kilometers away from Huanghua Airport, it has convenient transportation. The group covers an area of ​​130,000 square meters and currently has more than 200 employees. It has "Sanli Medical Technology, Benkang Plastic Products Branch, Reagent Project Department, Medical Glove Project Department" and other business industries. The total assets exceed 1 billion yuan and the annual output value reaches 800 million yuan. "Sanli" is a group enterprise integrating science, industry and trade. It is the earliest single-use automatic venous blood collector company in China and even Asia with excellent equipment, stable quality and high market share. Leading enterprises and blood collection vessel production bases. The group has formed a complete production chain in the production process of disposable automatic venous blood collectors. In addition to self-production and self-use, the supporting components, additives, automatic production lines of blood collectors are also sold to the vast number of blood collector manufacturers and scientific research institutions at home and abroad. The group's production, testing technology and equipment are at the forefront of the world. It has developed and produced more than 100 leading products of different specifications and functions. Glass pipes and PET pipes are sterile pipes. It is currently a domestically produced glass. Manufacturer of sterile tubes. "Sanli" participated in the formulation of vacuum blood collection industry standards. It is a sentinel unit for adverse event monitoring of vacuum blood collection products designated by the State Food and Drug Administration. It is a medical foreign aid training base designated by the Ministry of Commerce. In 2017, the total training came from 277 medical foreign aid workers in 126 countries. The group currently has 6 production workshops and 14 management departments, with more than 60 offices and more than 1,500 operating companies across the country are responsible for the company's product promotion and sales. In addition to the domestic market, the products are also sold to Asia, Europe, the United States and Africa. 74 countries including 32 in Asia, 18 in Africa, 15 in Europe, and 9 in the Americas; the group has passed ISO9001:2015 and ISO13485:2012 international quality management system certification and EU CE certification, providing strong guarantees for product quality . The "Three Forces" are a perfect combination of time, place and people, and are a beacon of scientific and technological innovation. Based in Asia, looking around the world, advocating people-oriented, keeping pace with the times, turning ideas and vows into motivation for hard work and progress, the "three forces" will surely become the leader in the global disposable automatic venous blood collector industry!

Headquartered in Chengdu hi-tech district, Chengdu Rich Science Industry Co., Ltd. is a hi-tech company with advanced research and development capability and first-class management. We are devoting ourselves to research, production and marketing of hi-tech medical, biological medical devices. Our main products are Vacuum Blood Collection System, body juice specimen collection system, bacteria culture/verification system, bio-informational products, instruments and medical reagents which are used extensively in the fields of pharmacology, test, teaching and science research.We have obtained ISO9001:2000, ISO13485:2003 certificate and CE approval in 2005. Based on our ontinuous principle of "C.D.RICH technology for society", we would like to make good cooperation with you.

CDRICH

Chengdu Rich Science Industry Co., Ltd.

Headquartered in Chengdu hi-tech district, Chengdu Rich Science Industry Co., Ltd. is a hi-tech company with advanced research and development capability and first-class management. We are devoting ourselves to research, production and marketing of hi-tech medical, biological medical devices. Our main products are Vacuum Blood Collection System, body juice specimen collection system, bacteria culture/verification system, bio-informational products, instruments and medical reagents which are used extensively in the fields of pharmacology, test, teaching and science research.We have obtained ISO9001:2000, ISO13485:2003 certificate and CE approval in 2005. Based on our ontinuous principle of "C.D.RICH technology for society", we would like to make good cooperation with you.

Hongyu Medical was founded in 2001, covering a total area of ​​150,000 square meters, 100,000-level purification workshop 20,000 square meters, and 14,000 square meters of clean workshop. With the joint efforts of all employees, Hongyu Medical has developed into this industry. Leading enterprises are gradually moving towards group companies with international competitiveness. Hongyu Medical has always adhered to the quality policy of "quality is our life and reputation is our foundation". It has now passed the ISO13485 international quality management system certification, the EU CE certification, and the US FDA registration. Hongyu Medical strictly abides by the quality management and control system to ensure stable product quality. Weihai Hongyu Medical Equipment Co., Ltd. mainly produces disposable vacuum blood collector series products, of which the annual output of vacuum blood collector series products is 500 million units, and is one of the major blood collector production enterprises in China. Hongyu Medical's vacuum blood collector, blood collecting needle and other products are exported to more than 30 countries and regions including Europe, Southeast Asia, Africa, the Middle East, South America, and North America, and are deeply trusted by customers. Hongyu Medical adheres to the business philosophy of "quality assurance, customer satisfaction, win-win cooperation", and works in unity and cooperation with suppliers and partners to provide customers with high-quality products and sincere and thoughtful services. Hongyu people have always been committed to medical care, constantly surpassing themselves and creating a healthier and better future!

Hongyu Medical

Weihai Hongyu Medical Devices Co., Ltd.

Hongyu Medical was founded in 2001, covering a total area of ​​150,000 square meters, 100,000-level purification workshop 20,000 square meters, and 14,000 square meters of clean workshop. With the joint efforts of all employees, Hongyu Medical has developed into this industry. Leading enterprises are gradually moving towards group companies with international competitiveness. Hongyu Medical has always adhered to the quality policy of "quality is our life and reputation is our foundation". It has now passed the ISO13485 international quality management system certification, the EU CE certification, and the US FDA registration. Hongyu Medical strictly abides by the quality management and control system to ensure stable product quality. Weihai Hongyu Medical Equipment Co., Ltd. mainly produces disposable vacuum blood collector series products, of which the annual output of vacuum blood collector series products is 500 million units, and is one of the major blood collector production enterprises in China. Hongyu Medical's vacuum blood collector, blood collecting needle and other products are exported to more than 30 countries and regions including Europe, Southeast Asia, Africa, the Middle East, South America, and North America, and are deeply trusted by customers. Hongyu Medical adheres to the business philosophy of "quality assurance, customer satisfaction, win-win cooperation", and works in unity and cooperation with suppliers and partners to provide customers with high-quality products and sincere and thoughtful services. Hongyu people have always been committed to medical care, constantly surpassing themselves and creating a healthier and better future!

Roche Diagnostics is committed to developing and providing innovative, cost-effective, timely and reliable diagnostic systems and solutions from early detection, prevention to diagnosis and monitoring of diseases, thereby helping medical staff improve patients' treatment effects and improve people's quality of life. Reduce social medical costs. Roche Group has two business areas: diagnostics and pharmaceuticals. This combination allows Roche Diagnostics to apply ground-breaking disease knowledge to develop innovative products, discover and monitor diseases, and guide the choice of treatment options. In August 2000, Luoche Diagnostic Products (Shanghai) Co., Ltd. was established as a wholly foreign-owned company in Shanghai Waigaoqiao Free Trade Zone to carry out business in mainland China. Since its establishment, the company's business has been growing and its scale has continued to grow. It is one of the leaders in the in vitro diagnostic market in China. To date, the company has more than 2,800 employees, distributed in 77 cities across the country. The company is headquartered in Shanghai and has established branches in Beijing, Guangzhou, Chengdu, Nanjing, Wuhan, Xi'an, Hangzhou, Jinan and Urumqi. The company's product sales and service network is spread all over the country. With its first-class technical products and perfect services, it has won a wide market and reputation. Roche Diagnostics has made a firm commitment to the Chinese market and will contribute to China's medical and healthcare cause and the improvement of people's quality of life by improving testing efficiency and medical value.

Roche Diagnostics

Roche Diagnostics Products (Shanghai) Co., Ltd.

Roche Diagnostics is committed to developing and providing innovative, cost-effective, timely and reliable diagnostic systems and solutions from early detection, prevention to diagnosis and monitoring of diseases, thereby helping medical staff improve patients' treatment effects and improve people's quality of life. Reduce social medical costs. Roche Group has two business areas: diagnostics and pharmaceuticals. This combination allows Roche Diagnostics to apply ground-breaking disease knowledge to develop innovative products, discover and monitor diseases, and guide the choice of treatment options. In August 2000, Luoche Diagnostic Products (Shanghai) Co., Ltd. was established as a wholly foreign-owned company in Shanghai Waigaoqiao Free Trade Zone to carry out business in mainland China. Since its establishment, the company's business has been growing and its scale has continued to grow. It is one of the leaders in the in vitro diagnostic market in China. To date, the company has more than 2,800 employees, distributed in 77 cities across the country. The company is headquartered in Shanghai and has established branches in Beijing, Guangzhou, Chengdu, Nanjing, Wuhan, Xi'an, Hangzhou, Jinan and Urumqi. The company's product sales and service network is spread all over the country. With its first-class technical products and perfect services, it has won a wide market and reputation. Roche Diagnostics has made a firm commitment to the Chinese market and will contribute to China's medical and healthcare cause and the improvement of people's quality of life by improving testing efficiency and medical value.

Cardinal Health is a global, integrated healthcare services and products company providing customized solutions for hospitals, pharmacies, and laboratories.

Cardinal Health

Cardinal Health, Inc.

Cardinal Health is a global, integrated healthcare services and products company providing customized solutions for hospitals, pharmacies, and laboratories.

Fresenius Cabi is a global enterprise focusing on the fields of infusion, blood transfusion and clinical nutrition. Fresenius Cabi provides reliable medical guarantees for patients with severe and chronic diseases with high-quality medicines, medical devices and services. Fresenius Cabi ’s product range includes intravenous medications, infusion therapy, clinical nutrition, and the medical devices required to apply these products. In the field of biosimilars, Fresenius Cabi focuses on autoimmune diseases and oncology. In terms of blood transfusion medicine and cell therapy devices, Fisseus Cabi provides blood component collection and in vitro cell therapy products. Taking care of life as its mission, Ferseniusca is committed to providing medical staff with essential medicines and technologies and helping them find quality solutions to solve problems. Since entering China, Fresenius Cabi has always regarded "caring for life" as the driving force for continuous development and progress, and is committed to helping the Chinese people improve their health and quality of life. Rooted in China for more than 30 years, Fresenius Cabi has been engaged in medicines, clinical nutrition, medical devices and other fields, thanks to its excellent products and technologies, standardized management, professional services, and efficient operation of R&D, production and marketing systems.业务领域取得骄人业绩,并发展成为中国临床营养、肾病营养治疗和麻醉治疗领域的领导者之一。

Fresenius Kabi

Fresenius Kabi (China) Investment Co., Ltd.

Fresenius Cabi is a global enterprise focusing on the fields of infusion, blood transfusion and clinical nutrition. Fresenius Cabi provides reliable medical guarantees for patients with severe and chronic diseases with high-quality medicines, medical devices and services. Fresenius Cabi ’s product range includes intravenous medications, infusion therapy, clinical nutrition, and the medical devices required to apply these products. In the field of biosimilars, Fresenius Cabi focuses on autoimmune diseases and oncology. In terms of blood transfusion medicine and cell therapy devices, Fisseus Cabi provides blood component collection and in vitro cell therapy products. Taking care of life as its mission, Ferseniusca is committed to providing medical staff with essential medicines and technologies and helping them find quality solutions to solve problems. Since entering China, Fresenius Cabi has always regarded "caring for life" as the driving force for continuous development and progress, and is committed to helping the Chinese people improve their health and quality of life. Rooted in China for more than 30 years, Fresenius Cabi has been engaged in medicines, clinical nutrition, medical devices and other fields, thanks to its excellent products and technologies, standardized management, professional services, and efficient operation of R&D, production and marketing systems.业务领域取得骄人业绩,并发展成为中国临床营养、肾病营养治疗和麻醉治疗领域的领导者之一。

Sarstedt's S-Monovette system is a versatile and safe blood collection system designed for both venous and capillary blood sampling.

Sarstedt S-Monovette

Sarstedt AG & Co. KG

Sarstedt's S-Monovette system is a versatile and safe blood collection system designed for both venous and capillary blood sampling.

Terumo Venosafe blood collection tubes are designed for safety and efficiency, ensuring accurate diagnostic results.

Terumo Venosafe

Terumo Corporation

Terumo Venosafe blood collection tubes are designed for safety and efficiency, ensuring accurate diagnostic results.

Popular Brands Recommended
Blood Collection Duct Product

版权所有 © 宁波全贸信息技术有限公司 浙ICP备12012821号-1 浙B2-20200628

浙公网安备 33020902000078号